US stock · US markets · public data

GILD

Gilead Sciences Inc · Healthcare

Reference price$152.28Updated according to the public source
P/E—
P/B15.98
ROE-20.68%
DY 12M2.11%
Net margin—
Net debt/equity—
Market capUS$ 188.8 B
Volume (shares)1,797,014
SectorHealthcare
Overview

About GILD

Demonstrações públicas consolidadas + SEC Company Facts

Gilead Sciences Inc (GILD) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
12/22
03/23
06/23
09/23
03/24
06/24
09/24
03/25
06/25
09/25
03/26
06/26
Income in shown records$9.30
DY 12M2.11%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$0.82
Period ending 2026-03-31Dividendo declarado$0.82
Period ending 2025-09-30Dividendo declarado$0.79
Period ending 2025-06-30Dividendo declarado$0.79
Period ending 2025-03-31Dividendo declarado$0.79
Period ending 2024-09-30Dividendo declarado$0.77

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$27,116,000,000.00$28,754,000,000.00$29,443,000,000.00—
Operating Income$7,605,000,000.00$1,662,000,000.00$10,022,000,000.00—
Net Income$5,665,000,000.00$480,000,000.00$8,510,000,000.00—

Balance sheet

Account2023202420252026
Total Assets$62,125,000,000.00$58,995,000,000.00$59,023,000,000.00—
Total Equity$22,749,000,000.00$19,246,000,000.00$22,618,000,000.00—
Long-term Debt$23,189,000,000.00$24,896,000,000.00$22,129,000,000.00—
Current Debt$1,798,000,000.00$1,815,000,000.00$2,807,000,000.00—
Shares Outstanding1,247,105,154 shares1,245,774,616 shares1,245,346,062 shares1,241,420,528 shares
Cash & Investments$8,427,000,000.00$9,991,000,000.00$10,606,000,000.00—
Dívida Líquida$16,560,000,000.00$16,720,000,000.00$14,330,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$8,006,000,000.00$10,828,000,000.00$10,019,000,000.00—
Capital Expenditures$585,000,000.00$523,000,000.00$563,000,000.00—
Dividends Paid$3,809,000,000.00$3,918,000,000.00$4,003,000,000.00—
Free Cash Flow$7,421,000,000.00$10,305,000,000.00$9,456,000,000.00—
FAQ

Frequently asked questions

What is the price of GILD?

The reference price available for GILD is $152.28.

What is the P/B of GILD?

The P/B of GILD is 15.98. This compares price with reported book value per share.

What is the ROE of GILD?

The ROE (Return on Equity) of GILD is -20.68%. This relates the reported net result to shareholders' equity.

What is the dividend yield of GILD?

The dividend yield of GILD is 2.11%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of GILD?

The market capitalization of GILD is US$ 188.8 B.

What sector is GILD in?

GILD operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.